Gas chromatographic analysis of dimethyltryptamine and β‐carboline alkaloids in ayahuasca, an amazonian psychoactive plant beverage
Ana Paula Salum Pires, Carolina Dizioli Rodrigues de Oliveira, Sidnei Moura, Felipe Augusto Dörr, Wagner Abreu E. Silva, Maurı́cio Yonamine
Phytochemical Analysis January 12, 2009 DOI: 10.1002/pca.1110 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Method development and validation Peer reviewed |
|---|---|
| Topics | Ayahuasca 5-MeO-DMT DMT |
| Keywords | Harmine Harmaline Gas chromatography Hallucinogen Traditional medicine |
| Citations | 74 |
| Key points | A simple gas chromatographic method to determine the main alkaloids in ayahuasca was developed and validated, with a lower limit of quantification of 0.02 mg/mL and linear range of 0.02–4.0 mg/mL. |
Abstract
Abstract Introduction Ayahuasca is obtained by infusing the pounded stems of Banisteriopsis caapi in combination with the leaves of Psychotria viridis . P . viridis is rich in the psychedelic indole N , N ‐dimethyltryptamine, whereas B . caapi contains substantial amounts of β ‐carboline alkaloids, mainly harmine, harmaline and tetrahydroharmine, which are monoamine‐oxidase inhibitors. Because of differences in composition in ayahuasca preparations, a method to measure their main active constituents is needed.
Objective: To develop a gas chromatographic method for the simultaneous determination of dimethyltryptamine and the main β ‐carbolines found in ayahuasca preparations. Methodology The alkaloids were extracted by means of solid phase extraction (C 18 ) and detected by gas chromatography with nitrogen/phosphorous detector.
Results: The lower limit of quantification (LLOQ) was 0.02 mg/mL for all analytes. The calibration curves were linear over a concentration range of 0.02–4.0 mg/mL ( r 2 > 0.99). The method was also precise (RSD < 10%).
Conclusion: A simple gas chromatographic method to determine the main alkaloids found in ayahuasca was developed and validated. The method can be useful to estimate administered doses in animals and humans for further pharmacological and toxicological investigations of ayahuasca. Copyright © 2009 John Wiley & Sons, Ltd.
Citations in the library
Cited by 49
- Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms Pharmacological Reviews December 16, 2020
- Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression ACS Chemical Neuroscience April 17, 2018
- Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice Physiology & Behavior January 28, 2015
- Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease. Journal of Ethnopharmacology April 21, 2010
- Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography-electrospray ionization-tandem mass spectrometry. Journal of Chromatography A December 18, 2009
and 44 more in the library
Cites 8
- Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of Ayahuasca Journal of Ethnopharmacology April 1, 1984
- Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics Journal of Pharmacology and Experimental Therapeutics June 18, 2003
- Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers Psychopharmacology February 22, 2001
- Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacology & Therapeutics May 1, 2004
- Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids Addiction December 20, 2006
and 3 more in the library